Chen JY, Ji QH, Bai C, Zheng X, et al. Surufatinib in Chinese patients with locally advanced or metastatic differentiated thyroid cancer and medullary thyroid cancer: A multicenter, open-label, Phase II trial. Thyroid 2020 Feb 19. doi: 10.1089/thy.2019.0453.
PMID: 32075524